Jocelyn Hudson

13 POSTS 0 COMMENTS

Study highlights declining venous stent patency rates after one year

A systematic review and meta-analysis of over 1,500 venous stenting procedures—said to be the first study on this topic to date—has highlighted an 18%...

Researchers develop machine learning models to predict IVC filter complications

Researchers in Canada have developed machine learning (ML) models that they claim, “can accurately predict one-year IVC filter complications, performing better than logistic...

FDA approves Humacyte’s Symvess for vascular trauma

ATEV
Humacyte recently shared that the Food and Drug Administration (FDA) has granted a full approval for the Symvess acellular tissue-engineered vessel. A press release notes...

Venous VQI celebrates decade milestone

At the recent VEITHsymposium (Nov. 19–23) in New York City, Marc Passman, MD, reflected on the achievements of the Society for Vascular Surgery (SVS)...

In search of the ‘holy grail’: New analysis brings aneurysm rupture...

A rupture prediction-based algorithm is set to enhance patient selection for abdominal aortic aneurysm (AAA) repair. This is according to Randy Moore, MD, a...

Endothermal ablation significantly outperforms surgery for varicose veins in long-term randomized...

Ten-year data from the randomized HELP trial show that, while both endothermal ablation and conventional surgery are effective treatments for great saphenous varicose veins...

BIO-OSCAR SOC trial examines standard of care in PAD treatment

Biotronik today announced that it has concluded the BIO-OSCAR SOC study evaluating the baseline against which to measure the Oscar multifunctional catheter in treating complex...

Microbot Medical announces FDA submission for commercialization of Liberty endovascular robotic...

Microbot Medical recently announced that it has submitted a 510(k) premarket notification to the Food and Drug Administration (FDA) for its Liberty endovascular robotic...

First patient enrolled in InspireMD’s CGUARDIANS II pivotal study

InspireMD today announced that the first patient has been enrolled in the company’s CGUARDIANS II clinical trial evaluating its CGuard Prime carotid stent system in...

One-year data from VenoValve US pivotal trial emerges

Envveno Medical has announced that it will present one-year data on all patients from the VenoValve US pivotal trial today at the VEITHsymposium (19–23 November, New York,...

Research suggests arm vein is the best alternative bypass conduit to...

A new analysis has found arm vein to be the most suitable alternative conduit to great saphenous vein (GSV) in chronic limb-threatening ischemia (CLTI)...

FDA grants R3 Vascular IDE approval for ELITE-BTK pivotal trial of...

R3 Vascular
R3 Vascular today announced that the Food and Drug Administration (FDA) has granted investigational device exemption (IDE) approval to initiate its ELITE-BTK pivotal trial...

CMS grants transitional pass-through payment for Medtronic’s Symplicity Spyral and Recor’s...

The Centers for Medicare and Medicaid Services (CMS) has granted transitional pass-through (TPT) payment for Medtronic's Symplicity Spyral renal denervation (RDN) catheter and Recor...

TCT 2024: One-year data from SIRONA trial show similar results for...

Data from the prospective, multicentre, investigator-initiated SIRONA randomised clinical trial demonstrated MagicTouch (Concept Medical) sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with...